Research - Montreal, Québec, Canada
HyperMabs is a biopharmaceutical company that designs and developsinnovative monoclonal antibody-based therapeutics for life threateningdiseases including COVID-19. We believe in connecting rigorous science withour innate sense of urgency to rapidly generate breakthrough therapies forpatients in need of a better quality of life. Our highly qualified team of drugdevelopers and company builders has a track record of advancing complexbiologics from discovery through clinical trials.
Gmail
Active Campaign
WP Engine
Microsoft Office 365
Google Cloud Hosting